RBC Capital Reiterates Outperform on Repligen, Maintains $190 Price Target
Portfolio Pulse from Benzinga Newsdesk
RBC Capital analyst Conor McNamara has reiterated an Outperform rating on Repligen (NASDAQ:RGEN) and maintained a price target of $190.
July 31, 2024 | 3:09 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
RBC Capital analyst Conor McNamara has reiterated an Outperform rating on Repligen and maintained a price target of $190.
The reiteration of an Outperform rating and a maintained price target of $190 by RBC Capital is a positive signal for Repligen. This suggests confidence in the company's future performance, likely leading to a short-term positive impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100